Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade Glioma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pamiparib and Low Dose Temozolomide In Patients With Platinum Sensitive Biliary Tract Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
- Status
- RECRUITING
- Phase
- PHASE2
Study of Pamiparib in Newly Diagnosed and rGBM
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ONO-4538 Phase II Rollover Study (ONO-4538-98)
- Status
- RECRUITING
- Phase
- PHASE2
Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma
- Status
- RECRUITING
- Phase
- PHASE1